Document:

EX-10.95

Exhibit 10.95

INVESTOR’S AGREEMENT

This Investor’s Agreement (this “Agreement”) is entered into this 26 day of October,
2005 by and among WARP Technology Holdings, Inc., a Nevada corporation (the “Company”) and
Platinum Equity, LLC (“Seller”).

RECITALS

1. The Company and Seller have entered into that certain Merger Agreement (the “Merger
Agreement), dated September 11, 2005, as amended, pursuant to which the Company is issuing to
Seller up to 8,863,636 shares of the Company’s Series D Preferred Stock (the “Series D
Stock”) which (subject to certain conditions on issuance and transfer) may be initially
converted into 8,863,636 shares of the Company’s common stock (“Common Stock”).

2. Pursuant to the Merger Agreement, the parties hereto are entering into this Agreement in
order to provide Seller with certain rights to register the Conversion Shares (as defined below).

AGREEMENT

Now, therefore, for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the parties hereto hereby agree as follows:

1. Definitions. For purposes of this Agreement (terms defined in the singular shall
apply to the plural form and vice-versa):

1.1 The terms “register,” “registered,” and “registration” refer to a
registration effected by preparing and filing a Registration Statement or similar document in
compliance with the Securities Act of 1933, as amended (the “Act”), and the declaration or
ordering of effectiveness of such Registration Statement or document by the SEC;

1.2 The term “Conversion Shares” means (i) the shares of Common Stock issuable on
conversion of the shares of Series D Stock, and (ii) any other shares of Common Stock of the
Company issued as (or issuable upon the conversion or exercise of any warrant, right or other
security which is issued as) a dividend or other distribution with respect to, or in exchange for
or in replacement of, such shares of Common Stock or Series D Stock. Notwithstanding the
foregoing, Common Stock or other securities shall only be treated as Conversion Shares if and so
long as they have not (A) been sold to or through a broker or dealer or underwriter in a public
distribution or a public securities transaction, or (B) been sold in a transaction exempt from the
registration and prospectus delivery requirements of the Act under Section 4(1) thereof so that all
transfer restrictions, and restrictive legends with respect thereto, if any, are removed upon the
consummation of such sale or (C) with regard to Seller, become eligible for sale pursuant to Rule
144(k).

1.3 The term “Series D Face Amount” means an amount equal to $1.10 for each share of
Series D Stock outstanding and held by Seller or an affiliate of Seller.

2. Registration Rights for Conversion Shares.

2.1 Registration of Conversion Shares. Within eighty (80) days (the “Filing
Deadline”) after the closing of the transaction contemplated by the Merger Agreement (the
“Closing”), the Company shall file a registration statement on Form SB-2 or an equally
suitable registration statement (the “Registration Statement”) for the purpose of
registering all of the Conversion Shares for resale. The Company shall use its best efforts to
cause such Registration Statement to be declared effective by the Securities and Exchange
Commission (the “SEC”) at the earliest practicable date thereafter. The Company will use
its best efforts to keep the Registration Statement effective (the “Effectiveness Period”)
(subject to reasonable blackout provisions as may be required in order to comply with the
securities laws) until the earlier of: (i) twenty four (24) months after the date that the
Registration Statement is declared effective by the SEC; (ii) the date when all of the Conversion
Shares covered by the Registration Statement are sold; or (iii) the date when Rule 144(k) is
available with respect to all of the securities covered by such Registration Statement. It is
agreed and understood that the Company shall, from time to time, be obligated to file an additional
Registration Statement (or an amendment to the Registration Statement) to cover any Conversion
Shares which are not registered for resale pursuant to a pre-existing Registration Statement.

2.2 Representations of Seller. Seller hereby represents to and covenants with the
Company that, during the period in which any Registration Statement effected pursuant to Section 2
remains effective, Seller will:

(a) not engage in any stabilization activity in connection with any of the Company’s
securities;

(b) cause to be furnished to any purchaser of the Conversion Shares and to the broker-dealer,
if any, through whom Conversion Shares may be offered, a copy of the final prospectus relating to
such Registration Statement; and

(c) not bid for or purchase any securities of the Company or any rights to acquire the
Company’s securities, or attempt to induce any person to purchase any of the Company’s securities
or any rights to acquire the Company’s securities, in each case, other than as permitted under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”).

2.3 Information for Use in Registration Statement. Seller covenants to the Company
that Seller will complete the information requested by the Questionnaire attached as Exhibit
B hereto (the “Questionnaire”), and further covenants to the Company that all
information provided by Seller in the Questionnaire will be true, accurate and complete as of the
date provided. Seller understands that the written information in the Questionnaire and all
written representations made in this Agreement are being provided to the Company specifically for
use in, or in connection with, the Registration Statement and the prospectus contained therein, and
has executed this Agreement with such knowledge.

2.4 Seller’s Piggy-Back Registrations. If at any time after the Filing Deadline and
prior to the expiration of the Effectiveness Period there is not an effective Registration
Statement covering all of the Conversion Shares and the Company shall determine to prepare and
file, or has filed, with the SEC a registration statement relating to an offering for its own
account or the account of others under the Act of any of its equity securities, other than (i) on
Form S-4 or Form S-8 (each as promulgated under the Act) or their then equivalents relating to
equity securities to be issued solely in connection with an acquisition of any entity or business
or equity securities issuable in connection with stock option or other employee benefit plans or
(ii) on Form S-3 (as promulgated under the Act) or its then equivalent relating to equity
securities to be issued solely in connection with a dividend reinvestment plan, then the Company
shall send to Seller written notice of such determination and, if within fifteen (15) days after
receipt of such notice, Seller shall so request in writing, the Company shall include in such
registration statement all or any part of such Conversion Shares that Seller requests to be
registered, subject to customary underwriter cutbacks applicable to all holders of registration
rights.

3. Registration Procedures. In connection with the Company’s registration obligations
hereunder, the Company shall:

(a) Not less than five (5) trading days prior to the filing of a Registration Statement or any
related prospectus or any amendment or supplement thereto, furnish to Seller copies of all such
documents proposed to be filed which documents (other than those incorporated by reference) will be
subject to the review of Seller. The Company shall not file a Registration Statement or any such
prospectus or any amendments or supplements thereto to which Seller shall reasonably object in
writing in good faith unless and until the Company shall have reasonably responded to the written
comments of Seller, including, without limitation, by making such changes to such Registration
Statement or any related prospectus or any amendment thereto as are necessary to reasonably address
such objection.

(b) (i) Prepare and file with the SEC such amendments, including post-effective amendments,
to each Registration Statement and the prospectus used in connection therewith as may be necessary
to (x) keep such Registration Statement continuously effective for the Effectiveness Period, and
(y) include any Conversion Shares held by any person who becomes a successor or assign of Seller (a
“Successor Holder”); such amendment shall be filed promptly after notice of transfer by
Seller to such Successor Holder has been provided to the Company (provided, that if the inclusion
of Conversion Shares held by a Successor Holder may be accomplished by a prospectus supplement, the
Company may, in lieu of filing an amendment to the Registration Statement, promptly prepare and
file pursuant to Rule 424 such prospectus supplement); (ii) cause the related prospectus to be
amended or supplemented by any required prospectus supplement, and as so supplemented or amended to
be filed pursuant to Rule 424; (iii) respond as promptly as reasonably possible, and in any event
within ten trading days, to any comments received from the SEC with respect to each Registration
Statement or any amendment thereto and, as promptly as reasonably possible provide to the Seller
true and complete copies of all correspondence from and to the SEC relating to such Registration
Statement that pertains to Seller as a selling stockholder but not any comments that would result
in the disclosure to Seller of material and non-public information concerning the Company; (iv)
prepare and file with the SEC such additional Registration Statements as may be required in order
to register for resale under the Act all of the Conversion Shares; and (v) comply in all material
respects with the provisions of the Act and the Exchange Act with respect to each Registration
Statement and the disposition of all Conversion Shares covered by each Registration Statement.

(c) Notify Seller in writing no later than two trading days following the day (i)(A) when the
SEC notifies the Company whether there will be a “review” of such Registration Statement and
whenever the SEC comments in writing on such Registration Statement (the Company shall provide to
Seller true and complete copies thereof and all written responses thereto that pertain to Seller as
a selling stockholder, but not information which the Company reasonably believes would constitute
material and non-public information); and (B) with respect to each Registration Statement or any
post-effective amendment, when the same has become effective; (ii) of any request by the SEC or any
other federal or state governmental authority for amendments or supplements to a Registration
Statement or prospectus or for additional information that pertains to Seller as a selling
stockholder; (iii) of the issuance by the SEC of any stop order suspending the effectiveness of a
Registration Statement covering any or all of the Conversion Shares or the initiation of any
proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect
to the suspension of the qualification or exemption from qualification of any of the Conversion
Shares for sale in any jurisdiction, or the initiation or threatening of any proceeding for such
purpose; and (v) subject to Section 3(j), of the occurrence of any event or passage of time that
makes the financial statements included in a Registration Statement ineligible for inclusion
therein or any statement made in such Registration Statement or prospectus or any document
incorporated or deemed to be incorporated therein by reference untrue in any material respect or
that requires any revisions to such Registration Statement, prospectus or other documents so that,
in the case of such Registration Statement or the prospectus, as the case may be, it will not
contain any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading.

(d) Use its reasonable best efforts to avoid the issuance of, or, if issued, to obtain the
withdrawal of (i) any order suspending the effectiveness of a Registration Statement, or (ii) any
suspension of the qualification (or exemption from qualification) of any of the Conversion Shares
for sale in any jurisdiction, at the earliest practicable moment.

(e) Furnish to Seller, without charge, at least one conformed copy of each Registration
Statement and each amendment thereto and all exhibits to the extent requested by Seller (including
those previously furnished or incorporated by reference) promptly after the filing of such
documents with the SEC.

(f) Promptly deliver to Seller, without charge, as many copies of each prospectus or
prospectuses and each amendment or supplement thereto as Seller may reasonably request. The
Company hereby consents to the use of such prospectus and each amendment or supplement thereto by
Seller in connection with the offering and sale of the Conversion Shares covered by such prospectus
and any amendment or supplement thereto.

(g) Prior to any public offering of Conversion Shares, use its reasonable best efforts to
register or qualify or cooperate with Seller in connection with the registration or qualification
(or exemption from such registration or qualification) of such Conversion Shares for offer and sale
under the securities or Blue Sky laws of those jurisdictions within the United States identified by
Seller to keep each such registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things necessary or advisable to
enable the disposition in such jurisdictions of the Conversion Shares covered by the Registration
Statements; provided, that the Company shall not be required to qualify generally to do
business or file a general consent to service of process in any jurisdiction where it is not then
so qualified or subject the Company to any material tax in any such jurisdiction where it is not
then so subject .

(h) Cooperate with Seller to facilitate the timely preparation and delivery of certificates
representing Conversion Shares to be delivered to a purchaser pursuant to the Registration
Statements, which certificates shall be free of all restrictive legends, and to enable such
Conversion Shares to be in such denominations and registered in such names as Seller may request.

(i) Upon the occurrence of any event contemplated by Section 3(c)(v), as promptly as
reasonably possible, prepare a supplement or amendment, including a post-effective amendment, to
the affected Registration Statement or a supplement to the related prospectus or any document
incorporated or deemed to be incorporated therein by reference, and file any other required
document so that, as thereafter delivered, no Registration Statement nor any prospectus will
contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading.

(j) The Company may require Seller to furnish to the Company a certified statement as to the
number of shares of Common Stock beneficially owned by Seller and any affiliate thereof and as to
any other information for Seller which the SEC requires to be disclosed in any Registration
Statements. For not more than twenty (20) consecutive days or for a total of not more than forty
(40) days in any twelve (12) month period, the Company may suspend the use of any prospectus
included in any Registration Statement in connection with any of the events described in Section
3(c)(ii)-(v) (an “Allowed Delay”); provided, that the Company shall promptly (a) notify
Seller in writing of the existence of (but in no event, without the prior written consent of
Seller, shall the Company disclose to Seller any of the facts or circumstances regarding) material
non-public information giving rise to an Allowed Delay, (b) advise Seller in writing to cease all
sales under the Registration Statement until the end of the Allowed Delay and (c) use reasonable
efforts to terminate an Allowed Delay as promptly as practicable. The periods set forth in Section
2.1 shall not be tolled during any Allowed Delay.

(k) Comply with all applicable rules and regulations of the SEC.

4. Registration Expenses. All fees and expenses incident to the Company’s performance
of its obligation under this Agreement (excluding any underwriting discounts and selling
commissions and all legal fees and expenses of legal counsel for Seller) shall be borne by the
Company whether or not any Conversion Shares are sold pursuant to a Registration Statement. The
fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all
registration and filing fees (including, without limitation, fees and expenses (A) payable to the
SEC in connection with the filing of a Registration Statement, (B) with respect to filings required
to be made with the trading market on which the Common Stock is then listed for trading, and (C) in
compliance with applicable state securities or Blue Sky laws), (ii) printing expenses (including,
without limitation, expenses of printing certificates for Conversion Shares and of printing
prospectuses if the printing of prospectuses is reasonably requested by the holders of a majority
of the Conversion Shares included in the Registration Statement), (iii) messenger, telephone and
delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Act liability
insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other
persons retained by the Company in connection with the consummation of the transactions
contemplated by this Agreement. In addition, the Company shall be responsible for all of its
internal expenses incurred in connection with the consummation of the transactions contemplated by
this Agreement (including, without limitation, all salaries and expenses of its officers and
employees performing legal or accounting duties), the expense of any annual or other audit or
review of its financial statements and the fees and expenses incurred in connection with the
listing of the Conversion Shares on any securities exchange as required hereunder.

5. Indemnification.

(a) Indemnification by the Company. The Company shall, notwithstanding any
termination of this Agreement, indemnify and hold harmless Seller, the officers, directors, agents,
investment advisors, partners, members, shareholders and employees of Seller, each person who
controls Seller or is under common control with Seller (within the meaning of Section 15 of the Act
or Section 20 of the Exchange Act) and the officers, directors, agents and employees of each such
controlling or commonly controlled person, to the fullest extent permitted by applicable law, from
and against any and all losses, claims, damages, liabilities, costs (including, without limitation,
reasonable costs of preparation and reasonable attorneys’ fees) and expenses (collectively,
“Losses”), as incurred, arising out of or relating to any untrue or alleged untrue
statement of a material fact contained in any Registration Statement, any prospectus or in any
amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission of a material fact required to be stated therein or necessary to
make the statements therein (in the case of any prospectus or supplement thereto, in light of the
circumstances under which they were made) not misleading, except to the extent, but only to the
extent (1) that such untrue statements or omissions are based solely upon information regarding
Seller furnished in writing to the Company by Seller expressly for use therein, or to the extent
that such information relates to Seller or Seller’s proposed method of distribution of Conversion
Shares and was reviewed and expressly approved in writing by Seller expressly for use in the
Registration Statement (it being understood that Seller has approved the Plan of Distribution
attached hereto as Annex A for this purpose), such prospectus or in any amendment or
supplement thereto, (2) arising from any offer or sale of Conversion Shares during a period in
which the Company has suspended use of the prospectus pursuant to Section 3(c)(ii)-(v) and of which
suspension Seller has been provided notice by the Company prior to such offer or sale, or (3) if
Seller fails to deliver, within the time required by the Act, a prospectus that is amended or
supplemented, to the extent, but only to the extent, that such prospectus, as amended or
supplemented, would have corrected the untrue statement or omission or alleged untrue statement or
omission of a material fact giving rise to such Loss contained in the prospectus delivered by
Seller, so long as the prospectus, as amended or supplemented, has been delivered to Seller by the
Company reasonably prior to such time. The Company shall notify Seller promptly of the institution,
threat or assertion of any proceeding of which the Company is aware in connection with the
transactions contemplated by this Agreement.

(b) Indemnification by Seller. Seller shall, notwithstanding any termination of this
Agreement, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each person who controls the Company (within the meaning of Section
15 of the Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees
of such controlling persons, to the fullest extent permitted by applicable law, from and against
all Losses, as incurred, arising solely out of or based solely upon: any untrue statement of a
material fact contained in any Registration Statement, any prospectus, or in any amendment or
supplement thereto, or arising solely out of or based solely upon any omission of a material fact
required to be stated therein or necessary to make the statements therein not misleading to the
extent, but only to the extent (1) that such untrue statements or omissions are based solely upon
information regarding Seller furnished in writing to the Company by Seller expressly for use
therein, or to the extent that such information relates to Seller or Seller’s proposed method of
distribution of Conversion Shares and was reviewed and expressly approved in writing by Seller
expressly for use in the Registration Statement (it being understood that Seller has approved the
Plan of Distribution attached hereto as Annex A for this purpose), such prospectus or in
any amendment or supplement thereto, (2) arising from any offer or sale of Conversion Shares during
a period in which the Company has suspended use of the prospectus pursuant to Section 3(c)(ii)-(v)
and of which suspension Seller has been provided notice by the Company prior to such offer or sale,
or (3) if Seller fails to deliver, within the time required by the Act, a prospectus that is
amended or supplemented, to the extent, but solely to the extent, that such prospectus, as amended
or supplemented, would have corrected the untrue statement or omission or alleged untrue statement
or omission of a material fact giving rise to such Loss contained in the prospectus delivered by
Seller, so long as the prospectus, as amended or supplemented, has been delivered to Seller by the
Company reasonably prior to such time. In no event shall the liability of Seller hereunder be
greater in amount than the dollar amount of the net proceeds received by Seller upon the sale of
the Conversion Shares giving rise to such indemnification obligation.

(c) Conduct of Indemnification Proceedings. If any proceeding shall be brought or
asserted against any person entitled to indemnity hereunder (an “Indemnified Party”), such
Indemnified Party shall promptly notify the person from whom indemnity is sought (the
“Indemnifying Party”) in writing, and the Indemnifying Party shall assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and
the payment of all fees and expenses incurred in connection with the defense thereof; provided,
that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent
that it shall be finally determined by a court of competent jurisdiction (which determination is
not subject to appeal or further review) that such failure shall have proximately and materially
adversely prejudiced the Indemnifying Party.

An Indemnified Party shall have the right to employ separate counsel in any such proceeding
and to participate in the defense thereof, but the fees and expenses of such counsel shall be at
the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in
writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to
assume the defense of such proceeding and to employ counsel reasonably satisfactory to such
Indemnified Party in any such proceeding; or (3) the named parties to any such proceeding
(including any impleaded parties) include both such Indemnified Party and the Indemnifying Party,
and such Indemnified Party shall have been advised by counsel that a conflict of interest is likely
to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party
(in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects
to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall
not have the right to assume the defense thereof and such counsel shall be at the expense of the
Indemnifying Party), provided, that the Indemnifying Party shall not be liable for the fees
and expenses of more than one separate firm of attorneys (in addition to local counsel) at any time
for all Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of any
such proceeding effected without its written consent, which consent shall not be unreasonably
withheld. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending proceeding in respect of which any Indemnified Party is or
could have been a party, unless such settlement includes an unconditional release of such
Indemnified Party from all liability on claims that are the subject matter of such proceeding.

All reasonable fees and expenses of the Indemnified Party (including reasonable fees and
expenses to the extent incurred in connection with investigating or defending such proceeding)
shall be paid to the Indemnified Party, as incurred, within ten trading days of written notice
thereof to the Indemnifying Party (regardless of whether it is ultimately determined that an
Indemnified Party is not entitled to indemnification hereunder; provided, that the Indemnifying
Party may require such Indemnified Party to undertake to reimburse all such fees and expenses to
the extent it is finally judicially determined that such Indemnified Party is not entitled to
indemnification hereunder).

(d) Contribution. If a claim for indemnification under Section 5(a) or 5(b) is
unavailable to an Indemnified Party (by reason of public policy or otherwise), then each
Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount
paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is
appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in
connection with the actions, statements or omissions that resulted in such Losses as well as any
other relevant equitable considerations. The relative fault of such Indemnifying Party and
Indemnified Party shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or
alleged omission of a material fact, has been taken or made by, or relates to information supplied
by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such action, statement or omission.

The parties hereto agree that it would not be just and equitable if contribution pursuant to
this Section 5(d) were determined by pro rata allocation or by any other method of allocation that
does not take into account the equitable considerations referred to in the immediately preceding
paragraph. Notwithstanding the provisions of this Section 5(d), Seller shall not be required to
contribute, in the aggregate, any amount in excess of the amount by which the proceeds actually
received by Seller from the sale of the Conversion Shares subject to the proceeding exceeds the
amount of any damages that Seller has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission.

The indemnity and contribution agreements contained in this Section are in addition to any
liability that the Indemnifying Parties may have to the Indemnified Parties.

6. Shares. The term “Shares” as used herein shall mean shares of Series D
Stock and the shares of Common Stock issued upon the conversion of the Series D Stock.

7. Transferability.

7.1 In General. Nothing herein shall limit the right of Seller to sell, convey or
transfer any of its Shares. The Shares may be disposed of only pursuant to an effective
registration statement under the Act, to the Company or pursuant to an available exemption from or
in a transaction not subject to the registration requirements of the Act, and in compliance with
any applicable state securities laws. In connection with any transfer of the Shares other than
pursuant to an effective registration statement, to the Company, to an affiliate of Seller or in
connection with a pledge as contemplated below, the Company may require the transferor thereof to
provide to the Company an opinion of counsel selected by the transferor and acceptable to the
Company (such acceptance not to be unreasonably withheld), the form and substance of which opinion
shall be reasonably satisfactory to the Company, to the effect that such transfer does not require
registration of such transferred Shares under the Act. The Company acknowledges and agrees that
Seller may from time to time pledge, and/or grant a security interest in some or all of the Shares,
in accordance with applicable securities laws, pursuant to a bona fide margin agreement in
connection with a bona fide margin account and, if required under the terms of such agreement or
account, Seller may transfer pledged or secured Shares to the pledgees or secured parties. Such a
pledge or transfer would not be subject to approval or consent of the Company and no legal opinion
of legal counsel to the pledgee, secured party or pledgor shall be required in connection with the
pledge, but such legal opinion may be required in connection with a subsequent transfer, following
default by Seller, to the transferee of the pledge. No notice shall be required of such pledge.
The Company will execute and deliver such reasonable documentation as a pledgee or secured party of
Shares may reasonably request in connection with a pledge or transfer of the Shares including,
without limitation, the preparation and filing of any required prospectus supplement under Rule
424(b)(3) of the Act or other applicable provision of the Act to appropriately amend the list of
selling stockholders thereunder.

7.2 Legend. Certificates evidencing the Shares will contain the following legend, so
long as is required by this Section 7 and applicable law:

THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF
COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

7.3 Removal of Legend. Certificates evidencing the Shares shall not contain any
legend (including, without limitation, the legend set forth in Section 7.2): (i) while a
registration statement (including, without limitation, the Registration Statement) covering the
resale of such Shares is effective under the Act or (ii) following any sale of such Shares pursuant
to Rule 144, or (iii) while such Shares are eligible for sale under Rule 144(k), or (iv) if such
legend is not required under applicable requirements of the Act (including, without limitation,
judicial interpretations and pronouncements issued by the Staff of the SEC). The Company shall use
its best efforts to cause its counsel to issue any legal opinion or instruction required by the
Company’s transfer agent to comply with the requirements set forth in this Section. At such time as
a legend is no longer required for the Shares under this Section 7.3, the Company will, no later
than five trading days following the delivery by Seller to the Company or the Company’s transfer
agent of a certificate representing Shares containing a restrictive legend, deliver or cause to be
delivered to Seller a certificate representing such Shares that is free from all restrictive and
other legends. The Company may not make any notation on its records or give instructions to any
transfer agent of the Company that enlarge the restrictions on transfer set forth in this Section
except as it may reasonably determine, upon written advice of counsel, are necessary to comply or
to ensure compliance with applicable laws; provided, however, that at such time as such notation or
enlarged restrictions are no longer necessary to comply or to ensure compliance with applicable
laws, the Company shall take such actions as are necessary to immediately eliminate such notation
or enlarged restrictions.

8. Governing Law. This Agreement and all acts and transactions pursuant hereto and
the rights and obligations of the parties hereto shall be governed, construed and interpreted in
accordance with the laws of the State of Delaware, without giving effect to principles of conflicts
of law.

9. Successors and Assigns. No party may assign its rights or obligations under this
Agreement, except with the prior written consent of the other party, provided that Seller
may assign its rights and its obligations without consent to the extent Seller transfers Shares in
accordance with the terms hereof. This Agreement shall be binding upon and shall inure to the
benefit of the parties hereto and their permitted successors and assigns.

10. Entire Agreement; Amendment; Termination. This Agreement, the Merger Agreement
and the agreements entered into in connection herewith and therewith constitute the full and entire
understanding and agreement between the parties with regard to the subject matter hereof and
thereof and supersede all prior agreements and understandings among the parties relating to the
subject matter hereof. Neither this Agreement nor any term hereof may be amended, waived,
discharged or terminated other than by a written instrument signed by the Company and Seller.

11. Notices. Unless otherwise provided herein, any notice required or permitted by
this Agreement shall be in writing and shall be deemed duly given upon delivery, when delivered
personally or by overnight courier and addressed to the party to be notified at such party’s
address as set forth on the signature page hereto, or as subsequently modified by written notice.
In the event that any date provided for in this Agreement falls on a Saturday, Sunday or legal
holiday, such date shall be deemed extended to the next business day.

12. Severability. If any term, provision, covenant or restriction of this Agreement
is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of
the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and
effect and shall in no way be affected, impaired or invalidated.

13. Captions and Headings. The captions and headings used herein are for convenience
and ease of reference only and are not intended to be a part of or to affect the meaning or
interpretation of this Agreement.

14. Waiver of Jury Trial. THE COMPANY AND SELLER HEREBY IRREVOCABLY WAIVES ANY AND
ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING RELATING TO OR ARISING OUT OF THIS AGREEMENT AND
THE TRANSACTIONS CONTEMPLATED HEREBY.

14. Counterparts. This Agreement may be executed in counterparts, and each such
counterpart shall be deemed an original for all purposes.

IN WITNESS WHEREOF, the parties hereto have caused this Investor’s Agreement to be executed by
their respective authorized representatives as of the date first written above.

WARP TECHNOLOGY HOLDINGS, INC.

By: /s/ Ernest C. Mysogland

Name: Ernest C. Mysogland

An authorized officer

PLATINUM EQUITY, LLC

By: /s/ Eva Kalawski

Name: Eva Kalawski

An authorized officer

1

ANNEX A

PLAN OF DISTRIBUTION

The selling stockholders, which as used herein includes donees, pledgees, transferees or other
successors-in-interest selling shares of common stock or interests in shares of common stock
received after the date of this prospectus from a selling stockholder as a gift, pledge,
partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise
dispose of any or all of their shares of common stock or interests in shares of common stock on any
stock exchange, market or trading facility on which the shares are traded or in private
transactions. These dispositions may be at fixed prices, at prevailing market prices at the time
of sale, at prices related to the prevailing market price, at varying prices determined at the time
of sale, or at negotiated prices.

The selling stockholders may use any one or more of the following methods when disposing of
shares or interests therein:

• ordinary brokerage transactions and transactions in which the broker-dealer solicits
purchasers;

• block trades in which the broker-dealer will attempt to sell the shares as agent, but may
position and resell a portion of the block as principal to facilitate the transaction;

• purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

• an exchange distribution in accordance with the rules of the applicable exchange;

• privately negotiated transactions;

• short sales;

• through the writing or settlement of options or other hedging transactions, whether through
an options exchange or otherwise;

• broker-dealers may agree with the selling stockholders to sell a specified number of such
shares at a stipulated price per share;

• a combination of any such methods of sale; and

• any other method permitted pursuant to applicable law.

The selling stockholders may, from time to time, pledge or grant a security interest in some
or all of the shares of common stock owned by them and, if they default in the performance of their
secured obligations, the pledgees or secured parties may offer and sell the shares of common stock,
from time to time, under this prospectus, or under an amendment to this prospectus under Rule
424(b)(3) or other applicable provision of the Securities Act amending the list of selling
stockholders to include the pledgee, transferee or other successors in interest as selling
stockholders under this prospectus. The selling stockholders also may transfer the shares of
common stock in other circumstances, in which case the transferees, pledgees or other successors in
interest will be the selling beneficial owners for purposes of this prospectus.

In connection with the sale of our common stock or interests therein, the selling stockholders
may enter into hedging transactions with broker-dealers or other financial institutions, which may
in turn engage in short sales of the common stock in the course of hedging the positions they
assume. The selling stockholders may also sell shares of our common stock short and deliver these
securities to close out their short positions, or loan or pledge the common stock to broker-dealers
that in turn may sell these securities. The selling stockholders may also enter into option or
other transactions with broker-dealers or other financial institutions or the creation of one or
more derivative securities which require the delivery to such broker-dealer or other financial
institution of shares offered by this prospectus, which shares such broker-dealer or other
financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect
such transaction).

The aggregate proceeds to the selling stockholders from the sale of the common stock offered
by them will be the purchase price of the common stock less discounts or commissions, if any. Each
of the selling stockholders reserves the right to accept and, together with their agents from time
to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly
or through agents. We will not receive any of the proceeds from this offering. Upon any exercise
of the warrants by payment of cash, however, we will receive the exercise price of the warrants.

The selling stockholders also may resell all or a portion of the shares in open market
transactions in reliance upon Rule 144 under the Securities Act of 1933, provided that they meet
the criteria and conform to the requirements of that rule.

The selling stockholders and any underwriters, broker-dealers or agents that participate in
the sale of the common stock or interests therein may be “underwriters” within the meaning of
Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn
on any resale of the shares may be underwriting discounts and commissions under the Securities Act.
Selling stockholders who are “underwriters” within the meaning of Section 2(11) of the Securities
Act will be subject to the prospectus delivery requirements of the Securities Act.

To the extent required, the shares of our common stock to be sold, the names of the selling
stockholders, the respective purchase prices and public offering prices, the names of any agents,
dealer or underwriter, any applicable commissions or discounts with respect to a particular offer
will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective
amendment to the registration statement that includes this prospectus.

In order to comply with the securities laws of some states, if applicable, the common stock
may be sold in these jurisdictions only through registered or licensed brokers or dealers. In
addition, in some states the common stock may not be sold unless it has been registered or
qualified for sale or an exemption from registration or qualification requirements is available and
is complied with.

We have advised the selling stockholders that the anti-manipulation rules of Regulation M
under the Exchange Act may apply to sales of shares in the market and to the activities of the
selling stockholders and their affiliates. In addition, we will make copies of this prospectus (as
it may be supplemented or amended from time to time) available to the selling stockholders for the
purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling
stockholders may indemnify any broker-dealer that participates in transactions involving the sale
of the shares against certain liabilities, including liabilities arising under the Securities Act.

We have agreed to indemnify the selling stockholders against liabilities, including
liabilities under the Securities Act and state securities laws, relating to the registration of the
shares offered by this prospectus.

We have agreed with the selling stockholders to keep the registration statement of which this
prospectus constitutes a part effective until the earlier of (1) 24 months after the registration
statement is declared effective by the Securities and Exchange Commission, (2) the date when all of
the shares covered by this prospectus have been disposed of pursuant to and in accordance with the
registration statement or (3) the date on which all of the shares covered by this prospectus may be
sold pursuant to Rule 144(k) of the Securities Act.

2

EXHIBIT B

WARP TECHNOLOGY HOLDINGS, INC.

SELLING INVESTOR’S QUESTIONNAIRE AND COVENANT

[To be completed and executed prior to the filing of the Registration Statement.]

In connection with the WARP Technology Holdings, Inc. (the “Company”) Registration on Form
SB-2 (the “Registration Statement”)to be filed on or about      , 2005 with the
Securities and Exchange Commission (the “SEC”) registering certain shares (the “Shares”) of
the Company’s Common Stock that are issuable on conversion of the outstanding shares of Series d
Preferred Stock, the undersigned represents, warrants and covenants as follows:

1. As of the date hereof, the undersigned beneficially owns the number of shares of the
Company’s Common Stock set forth opposite his, her or its name on Exhibit A attached
hereto.

2. The persons listed on Exhibit A represent all of the individuals who exercise
voting or dispositive power over the Shares to be included pursuant to the Registration Statement.

3. The undersigned hereby represents that it understands that, pursuant to Interpretation A.65
in the SEC Division of Corporation Finance, Manual of Publicly Available Telephone Interpretations
dated July 1997, a copy of which is attached as Exhibit B hereto, the undersigned may not
make any short sale of the Shares prior to the effectiveness of the Registration Statement.

4. Other than as a shareholder in the Company, the undersigned has not had a material
relationship with the Company or any of its predecessors or affiliates within the last three years.

The term “material relationship” has not been defined by the SEC. However, the SEC has
indicated that it will probably construe as a “material relationship” any relationship which tends
to prevent arms length bargaining in dealings with a company, whether arising from a close business
connection or family relationship, a relationship of control or otherwise. It seems prudent,
therefore, to consider that the undersigned would have such a relationship, for example, with any
organization of which the undersigned is an officer, director, trustee or partner or in which the
undersigned owns, directly or indirectly, 10% or more of the outstanding voting stock, or in which
the undersigned has some other substantial interest, and with any person or organization with whom
the undersigned has, or with whom any relative or spouse (or any other person or organization as to
which the undersigned has any of the foregoing other relationships) has, a contractual
relationship.

Exceptions:

5. The undersigned hereby covenants to the Company that, during the period in which the
Registration Statement is effective, the undersigned will:

(a) not engage in any stabilization activity in connection with any of the Company’s
securities;

(b) cause to be furnished to any purchaser of the Shares and to the broker-dealer, if any,
through which the Shares may be offered, a copy of the final prospectus contained in the
Registration Statement;

(c) not bid for or purchase any securities of the Company or any rights to acquire the
Company’s securities, or attempt to induce any person to purchase any of the Company’s securities
or any rights to acquire the Company’s securities other than as permitted under the Securities
Exchange Act of 1934;

(d) not effect any sale or distribution of the Shares until after the prospectus has been
appropriately amended or supplemented, if required; and

(e) effect all sales, distributions or gifts of shares in accordance with the plan of
distribution described in the section of the Registration Statement entitled “Plan of
Distribution,” a draft of which has been provided as Annex A to the Investors’ Agreement.

6. The undersigned acknowledges that the information set forth in this questionnaire will be
used by the Company in connection with the registration of the Shares, and is true, accurate and
complete.

IN WITNESS WHEREOF, the undersigned declares that the above information is true, accurate and
complete.

NAME OF INVESTOR:

(PRINT OR TYPE)

	 	 	 	 	 
	Dated:      

	 	By:
	 	

	
 
	 	 
	 	 
	
 
	 	 	 	(signature)
	 
	 	 	 	 
	
 
	 	Name:
	 	

	
 
	 	 	 	 
	 
	 	 	 	 
	
 
	 	Title:
	 	

	
 
	 	 
	 	 

3

(if applicable)EXHIBIT A

	 	1.	 	Shares of WARP Technology Holdings, Inc. stock beneficially owned as of the date hereof
(please complete):

Shares of Series D Preferred Stock: .

Shares of Common Stock issuable on conversion of the Series D Preferred Stock:
     .

Other WARP Technology shares held: .

Other warrants or options to purchase shares of WARP Technology stock that are exercisable within
60 days after the estimated filing date:      .

	 	2.	 	If the shares are held by an entity, you must list the natural person who holds sole voting
and dispositive power over the shares held (or if more than one natural person shares voting
and dispositive power, you must list all of the natural persons who share voting and
dispositive power over the shares). So, for example, a disclosure may read as follows:

“The shares held on behalf of [selling Investor] are managed by its managing member, XYZ
Corp., LLC. The [officers][managing directors] of XYZ Corp., LLC, who share voting and
dispositive power over the shares, are John Brown and Harry Smith.”

Name of natural person(s) with voting and dispositive power over the shares:

     

     

     

The undersigned agrees with the information set forth on this Exhibit A and
acknowledges that such information will be used in connection with the registration of the shares.

4

Name of Selling Investor:

Print Name:

By (signature):

Title:

Date:

5

EXHIBIT B

Interpretation A.65 from the Securities and Exchange Commission, Division of Corporation Finance,
Manual of Publicly Available Telephone Interpretations dated July 1997:

“An issuer filed a Form S-3 registration statement for a secondary
offering of common stock which is not yet effective. One of the selling
shareholders wanted to do a short sale of common stock “against the box”
and cover the short sale with registered shares after the effective date.
The issuer was advised that the short sale could not be made before the
registration statement becomes effective, because the shares underlying
the short sale are deemed to be sold at the time such sale is made. There
would, therefore, be a violation of Section 5 if the shares were
effectively sold prior to the effective date.”

6EX-10.96

Exhibit 10.96

PROMISSORY NOTE

$1,750,000

Issue Date: October 26, 2005 Maturity Date: March 31, 2006

FOR VALUE RECEIVED, Warp Technology Holdings, Inc. (the “Company”) hereby promises to
pay to the order of Platinum Equity, LLC or its successors, assigns and legal representatives (the
“Holder”), at 360 N. Crescent Drive, South Building, Beverly Hills, California 90210, or at
such other location as the Holder may designate from time to time, the aggregate principal sum of
$1,750,000 (One Million Seven Hundred Fifty Thousand Dollars), in lawful money of the United States
of America, together with interest thereon at a rate of 9.0% per annum. This Promissory Note (this
“Note”) is delivered pursuant to that certain Merger Agreement, dated as of September 11,
2005, between the Company, TAC/Halo, Inc. and the Holder, as amended subsequent to the execution
thereof (the “Purchase Agreement”).

1. Maturity Date. Subject to the provisions of Section 5 below, the aggregate
principal amount of this Note and accrued interest thereon shall be due and payable on March 31,
2006 (the “Maturity Date”).

2. Calculation and Payment of Interest. Interest shall be payable in registered
shares of common stock of the Company (“Common Stock”), provided that until such shares are
registered, interest shall be paid in cash. If interest is paid in shares of Common Stock,
interest will be paid in full shares only, with an additional share to be paid for any fractional
share. Interest hereunder shall be calculated on the basis of a 360-day year for the actual number
of days elapsed. Interest shall be calculated on a simple interest basis and shall accrue daily
and be payable in arrears on the Maturity Date.

3. Prepayment. Any prepayments hereunder shall be applied first, to the payment of
any expenses then owed to the Holder, second, to accrued interest on this Note and third, to the
payment of the principal amount outstanding under this Note. The Company shall not have the right
to set off or otherwise deduct from amounts payable by it hereunder any amounts whether liquidated
or unliquidated, which the Holder or any of its Affiliates may owe to the Company, which right is
hereby expressly waived to the maximum extent permitted by applicable law. The Company shall have
the right to prepay all or a portion of this Note.

4. Covenants. The Company agrees that, so long as any amount payable under this Note
remains unpaid, it will not, and will cause its Subsidiaries not to, without the prior written
consent of the Holder:

(a) create, incur, guarantee, issue, assume or in any manner become liable in respect of, any
obligation (i) for borrowed money, other than trade payables incurred in the ordinary course of
business, (ii) evidenced by bonds, debentures, notes, or other similar instruments, (iii) in
respect of letters of credit or other similar instruments (or reimbursement obligations with
respect thereto), except letters of credit or other similar instruments issued to secure payment of
trade payables arising in the ordinary course of business consistent with past practices, (iv) to
pay the deferred purchase price of property or services, except trade payables arising in the
ordinary course of business consistent with past practices, (v) secured by a Lien (as defined
below) on any asset of the Company or a Subsidiary, whether or not such obligation is assumed by
the Company or such Subsidiary and (vi) of any other person or entity, other than (i) indebtedness
for borrowed money under the Credit Agreement, dated August 2, 2005, between Fortress Credit Corp.,
the Company and certain subsidiaries of the Company, as such Credit Agreement may be amended from
time to time (the “Fortress Credit Agreement”); (ii) indebtedness for borrowed money existing on
the date of this Note; (iii) any indebtedness (including under finance or capital leases) relating
to the acquisition of equipment or computers in the ordinary course of business; (iv) indebtedness
incurred as a result of a Company financing consummated through an offering of convertible
subordinated promissory notes of the Company, so long as (x) the maturity date for these
obligations falls after the Maturity Date, and (y) these notes have a priority equal or subordinate
to this Note; and (v) obligations or liabilities incurred in connection with Liens permitted to be
incurred under Section 4(b)(vi), 4(b)(vii) and 4(b)(viii) hereof;

(b) create, incur, assume or suffer to exist any lien, claim, pledge, charge, security
interest or encumbrance of any kind (“Liens”) on any asset now owned or hereafter acquired
by it, except:

(i) Liens existing on the date hereof;

(ii) Liens for taxes or assessments and similar charges either (x) not delinquent or (y)
contested in good faith by appropriate proceedings and as to which the Company shall have set aside
on its books adequate reserves;

(iii) Liens incurred or pledges and deposits in connection with workers’ compensation,
unemployment insurance and other social security benefits, or securing the performance bids,
tenders, leases, contracts (other than for the repayment of borrowed money), statutory obligations,
progress payments, surety and appeal bonds and other obligations of like nature, incurred in the
ordinary course of business;

(iv) Liens imposed by law, such as mechanics’, carriers’, warehousemen’s, materialmen’s and
vendors’ Liens, incurred in good faith in the ordinary course of business;

(v) zoning restrictions, easements, licenses, covenants, reservations, restrictions on the use
of real property or minor irregularities of title incident thereto which do not in the aggregate
materially detract from the value of the property or assets of the Company and its Subsidiaries
taken as a whole or impair the use of such property in the operation of the Company’s or its
Subsidiaries’ businesses; and

(vi) other Liens incidental to the conduct of the business of the Company or a subsidiary
thereof or the ownership of its or their respective property and assets which were not incurred in
connection with the borrowing of money, and which do not in the aggregate materially detract from
the value of its property or assets;

(vii) Liens created by purchase money security interests in equipment or computers acquired by
the Company in the ordinary course of business; or

(viii) Liens incurred under the Fortress Credit Agreement.

(c) declare or make (i) any dividend, distribution or other payment on any capital stock
(other than the payment of dividends on the Company’s Series B Preferred Stock and Series B-2
Preferred Stock, which are payable in shares of Common Stock upon the conversion of such Series B
Preferred Stock and Series B-2 Preferred Stock, and the payment of dividends on the Company’s
Series C Preferred Stock, which are payable in either cash or shares of Common Stock, at the
election of the Company) or (ii) any payment on account of the purchase, redemption, retirement or
acquisition of (A) any capital stock or (B) any option, warrant or other right to acquire capital
stock.

5. Events of Default. Each of the following shall constitute an “Event of Default”
hereunder:

(a) The Company shall fail to pay the principal amount of this Note and accrued interest
thereon when due and payable (whether at the Maturity Date, upon acceleration or otherwise);

(b) The Company shall fail to pay any other amount under this Note when due and payable
(whether at the maturity date therefor, upon acceleration or otherwise) and such failure shall
continue for a period of five (5) business days;

(c) Any representation or warranty made by the Company in the Transaction Documents shall have
been untrue or misleading in any material respect when made;

(d) There shall have occurred an acceleration of the stated maturity of any indebtedness for
borrowed money of the Company or any Subsidiary of Fifty Thousand Dollars ($50,000) or more in
aggregate principal amount (which acceleration is not rescinded, annulled or otherwise cured within
ten (10) days of receipt by the Company or such Subsidiary of notice of such acceleration);

(e) The Company shall sell, transfer, lease or otherwise dispose of all or any substantial
portion of its assets in one transaction or a series of related transactions, participate in any
share exchange, consummate any recapitalization, reclassification, reorganization or other business
combination transaction or adopt a plan of liquidation or dissolution or agree to do any of the
foregoing;

(f) One or more judgments in an aggregate amount in excess of Fifty Thousand Dollars ($50,000)
shall have been rendered against the Company or any subsidiary and such judgment or judgments
remain undischarged or unstayed for a period of sixty (60) days after such judgment or judgments
become or became, as the case may be, final and unappealable;

(g) The Company breaches any covenant set forth in Section 4 hereof.

(h) The Company shall have applied for or consented to the appointment of a custodian,
receiver, trustee or liquidator, or other court-appointed fiduciary of all or a substantial part of
its properties; or a custodian, receiver, trustee or liquidator or other court appointed fiduciary
shall have been appointed with or without the consent of the Company; or the Company is generally
not paying its debts as they become due by means of available assets, or has made a general
assignment for the benefit of creditors; or the Company files a voluntary petition in bankruptcy,
or a petition or an answer seeking reorganization or an arrangement with creditors or seeking to
take advantage of any insolvency law, or an answer admitting the material allegations of a petition
in any bankruptcy, reorganization or insolvency proceeding or has taken action for the purpose of
effecting any of the foregoing; or if, within sixty (60) days after the commencement of any
proceeding against the Company seeking any reorganization, rehabilitation, arrangement,
composition, readjustment, liquidation, dissolution or similar relief under the Federal bankruptcy
code or similar order under future similar legislation, the appointment of any trustee, receiver,
custodian, liquidator, or other court-appointed fiduciary of the Company or of all or any
substantial part of its properties, such order or appointment shall not have been vacated or stayed
on appeal or otherwise or if, within sixty (60) days after the expiration of any such stay, such
order or appointment shall not have been vacated (collectively, “Insolvency Events”); or

(i) Any Insolvency Event shall have occurred with respect to any subsidiary of the Company.

Upon the occurrence of any Event of Default, the Holder may, at its option, declare all
amounts owed hereunder to be due and payable immediately and, upon any such declaration, the same
shall become and be immediately due and payable. If an Insolvency Event occurs with respect to the
Company or any Subsidiary, then all amounts due hereunder shall become immediately due and payable
without any declaration or other act on the part of the Holder. Upon the occurrence of any Event
of Default, the Holder may, in addition to declaring all amounts due hereunder to be immediately
due and payable, pursue any available remedy. If an Event of Default occurs, the Company shall pay
to the Holder the reasonable attorneys’ fees and disbursements and all other reasonable
out-of-pocket costs incurred by the Holder in order to collect amounts due and owing under this
Note or otherwise to enforce the Holder’s rights and remedies hereunder.

6. Waiver of Presentment, Demand and Dishonor. The Company hereby waives presentment
for payment, protest, demand, notice of protest, notice of non-payment and diligence with respect
to this Note, and waives and renounces all rights to the benefit of any statute of limitations or
any moratorium, appraisement, exemption or homestead now provided or that hereafter may be provided
by any federal or applicable state statute, including but not limited to exemptions provided by or
allowed under the Federal Bankruptcy Code, both as to itself and as to all of its property, whether
real or personal, against the enforcement and collection of the obligations evidenced by this Note
and any and all extensions, renewals and modifications hereof.

No failure on the part of the Holder hereof to exercise any right or remedy hereunder with
respect to the Company, whether before or after the happening of an Event of Default, shall
constitute a waiver of any future Event of Default or of any other Event of Default. No failure to
accelerate the debt of the Company evidenced hereby by reason of an Event of Default or indulgence
granted from time to time shall be construed to be a waiver of the right to insist upon prompt
payment thereafter; or shall be deemed to be a novation of this Note or a reinstatement of such
debt evidenced hereby or a waiver of such right of acceleration or any other right, or be construed
so as to preclude the exercise of any right the Holder may have, whether by the laws of the state
governing this Note, by agreement or otherwise; and the Company hereby expressly waives the benefit
of any statute or rule of law or equity that would produce a result contrary to or in conflict with
the foregoing.

7. Amendment; Waiver. Any term of this Note may be amended or waived upon the written
consent of the Company and the Holder hereof. No such waiver or consent on any one instance shall
be construed to be a continuing waiver or a waiver in any other instance unless it expressly so
provides.

8. Transfers. The Holder shall have the right to transfer this Note or any interest
herein in any transaction meeting the requirements of applicable securities laws. The Company may
not transfer any obligations under this Note without the prior written consent of Holder.

9. Governing Law; Consent to Jurisdiction. This Note shall be binding upon the
Company and its successors, assigns and legal representatives. The validity, construction and
interpretation of this Note will be governed, and construed in accordance with, the laws of the
State of California. EACH OF THE COMPANY AND, BY ITS ACCEPTANCE HEREOF, THE HOLDER HEREBY WAIVES
ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS NOTE AND REPRESENTS
THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

All notices under this Note, including any service of process in connection with any suit, action
or proceeding with respect to this Note may be served on the Company and the Holder anywhere in the
world by the same methods as are specified for the giving of notices under Section 10.8 of the
Purchase Agreement.

WARP TECHNOLOGY HOLDINGS, INC.

By: /s/ Ernest C. Mysogland

Name: Ernest C. Mysogland

An authorized officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}]]